260 related articles for article (PubMed ID: 9415560)
1. Infectivity of hepatic allografts with antibodies to hepatitis B virus.
Dodson SF; Issa S; Araya V; Gayowski T; Pinna A; Eghtesad B; Iwatsuki S; Montalvo E; Rakela J; Fung JJ
Transplantation; 1997 Dec; 64(11):1582-4. PubMed ID: 9415560
[TBL] [Abstract][Full Text] [Related]
2. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
[TBL] [Abstract][Full Text] [Related]
3. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
4. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
Holt D; Thomas R; Van Thiel D; Brems JJ
Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
[TBL] [Abstract][Full Text] [Related]
5. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience.
Pan JJ; Oh SH; Soldevila-Pico C; Nelson DR; Liu C
Clin Transplant; 2011; 25(1):164-70. PubMed ID: 20156222
[TBL] [Abstract][Full Text] [Related]
7. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Cholongitas E; Papatheodoridis GV; Burroughs AK
J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
[TBL] [Abstract][Full Text] [Related]
10. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
[TBL] [Abstract][Full Text] [Related]
11. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
[TBL] [Abstract][Full Text] [Related]
12. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
[TBL] [Abstract][Full Text] [Related]
13. [Risk of hepatitis B virus transmission from hepatitis B core antibody-positive liver donors].
Bárcena Marugán R; García Garzón S; López San Román A; Peña González E; Nasha R; Férnandez Muñoz R; Mateos M; García Plaza A
Med Clin (Barc); 2001 Feb; 116(4):125-8. PubMed ID: 11222157
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
[TBL] [Abstract][Full Text] [Related]
15. Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.
Dodson SF
Clin Transplant; 2000; 14 Suppl 2():20-4. PubMed ID: 10965960
[TBL] [Abstract][Full Text] [Related]
16. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB
Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059
[TBL] [Abstract][Full Text] [Related]
17. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
[TBL] [Abstract][Full Text] [Related]
18. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
19. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
[TBL] [Abstract][Full Text] [Related]
20. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]